Platinum Investment Management Ltd. Invests $286,000 in UnitedHealth Group Incorporated $UNH

Key Points

• Platinum Investment Management Ltd. has invested approximately $286,000 in UnitedHealth Group, acquiring 917 shares in the healthcare company during the second quarter.
• UnitedHealth Group's recent earnings report showed a quarterly EPS of $4.08, which fell short of expectations, while the company had a revenue of $111.62 billion.
• The firm announced a quarterly dividend of $2.21 per share, representing an annualized dividend of $8.84, which yields 2.5% and reflects a dividend payout ratio of 38.30%.

Platinum Investment Management Ltd. bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the second quarter, according to its most recent disclosure with the SEC. The firm bought 917 shares of the healthcare conglomerate's stock, valued at approximately $286,000.

A number of other institutional investors also recently bought and sold shares of UNH. Brighton Jones LLC raised its holdings in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC lifted its position in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after acquiring an additional 2,324 shares in the last quarter. RFG Advisory LLC lifted its position in shares of UnitedHealth Group by 13.5% in the first quarter. RFG Advisory LLC now owns 5,263 shares of the healthcare conglomerate's stock valued at $2,756,000 after acquiring an additional 628 shares in the last quarter. Hennion & Walsh Asset Management Inc. lifted its position in shares of UnitedHealth Group by 2.2% in the first quarter. Hennion & Walsh Asset Management Inc. now owns 13,065 shares of the healthcare conglomerate's stock valued at $6,843,000 after acquiring an additional 281 shares in the last quarter. Finally, Apella Capital LLC lifted its position in shares of UnitedHealth Group by 44.1% in the first quarter. Apella Capital LLC now owns 1,682 shares of the healthcare conglomerate's stock valued at $973,000 after acquiring an additional 515 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have recently commented on UNH shares. Cantor Fitzgerald restated an "overweight" rating and issued a $440.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, August 26th. JPMorgan Chase & Co. lowered their price objective on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a research report on Wednesday, August 6th. Morgan Stanley boosted their target price on UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a research report on Friday, September 12th. Wells Fargo & Company decreased their target price on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Finally, Robert W. Baird reiterated an "underperform" rating and issued a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $358.95.

UnitedHealth Group Trading Up 0.7%

Shares of NYSE UNH opened at $347.82 on Thursday. The business's 50 day moving average is $304.76 and its two-hundred day moving average is $357.57. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The stock has a market capitalization of $315.01 billion, a P/E ratio of 15.07, a PEG ratio of 2.25 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the previous year, the firm earned $6.80 earnings per share. The company's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group's dividend payout ratio is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.